Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

INTRODUCTION: Schizophrenia, although a debilitating mental illness, greatly affects individuals physical health as well. One of the leading somatic comorbidities associated with schizophrenia is cardiovascular disease, which has been estimated to be one of the leading causes of excess mortality in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna I. Tkachev, Elena A. Stekolshchikova, Anna Yu. Morozova, Nikolay A. Anikanov, Yana A. Zorkina, Polina N. Alekseyeva, Elena B. Khobta, Denis S. Andreyuk, Svetlana A. Zozulya, Alexandra N. Barkhatova, Tatiana P. Klyushnik, Alexander M. Reznik, Georgiy P. Kostyuk, Philipp E. Khaitovich
Formato: article
Lenguaje:EN
RU
Publicado: Eco-Vector 2021
Materias:
ceramide
schizophrenia
cardiovascular disease
lipid
blood plasma
Psychiatry
RC435-571
Psychology
BF1-990
Acceso en línea:https://doaj.org/article/469e7b26d5674e168ba9c2677ee37fea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/469e7b26d5674e168ba9c2677ee37fea

Ejemplares similares